Case report: adrenal oncocytoma associated with markedly increased FDG uptake and immunohistochemically positive for GLUT1

Endocr Pathol. 2014 Dec;25(4):410-5. doi: 10.1007/s12022-014-9337-4.

Abstract

Usually, benign tumors are not associated with an increased F-18 fluorodeoxyglucose (F-18 FDG) uptake on positron emission tomography (PET), although some exceptions have been reported in adrenal neoplasms. We present a rare case of adrenocortical oncocytoma associated with markedly increased FDG uptake, demonstrating a maximum standardized uptake value of 46.8. Histological examination demonstrated diffuse proliferation of tumor cells with eosinophilic and granular cytoplasm that were diffusely immunopositive for mitochondria and glucose transport protein 1, with focal and weak immunopositivity for 3β-hydroxysteroid dehydrogenase. Ultrastructural examination also revealed abundant mitochondria in the tumor cells. The tumor was diagnosed as adrenocortical oncocytoma and was considered benign according to Lin-Weiss-Bisceglia criteria. Diagnosis of adrenocortical oncocytoma can pose difficulties during both preoperative radiological and postoperative histopathological investigations.

Publication types

  • Case Reports

MeSH terms

  • Adenoma, Oxyphilic / diagnosis
  • Adenoma, Oxyphilic / diagnostic imaging
  • Adenoma, Oxyphilic / metabolism*
  • Adrenal Cortex Neoplasms / diagnosis
  • Adrenal Cortex Neoplasms / diagnostic imaging
  • Adrenal Cortex Neoplasms / metabolism*
  • Adult
  • Female
  • Fluorodeoxyglucose F18 / pharmacokinetics*
  • Glucose Transporter Type 1 / metabolism*
  • Humans
  • Immunohistochemistry
  • Microscopy, Electron
  • Positron-Emission Tomography / methods
  • Radiopharmaceuticals / pharmacokinetics*

Substances

  • Glucose Transporter Type 1
  • Radiopharmaceuticals
  • SLC2A1 protein, human
  • Fluorodeoxyglucose F18